Author: Renubresearch01

Global Led Lighting Market, Size, Share, Growth and Key players | Forecast (2023 – 2028)

Comprehensive industry analysis and market share data in the recently released report “Global LED Lighting Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2030″ by Renub Research. The report also analyses competitors, geographical areas, and expansion for LED Lighting Market.

A CAGR of 10.12% is projected for the LED lighting market between 2023 and 2030.The transition to LED lighting is a significant and positive shift in the lighting industry. LEDs’ energy efficiency and durability have made them a preferred choice for consumers and businesses. The U.S. Department of Energy statistics highlight the rapid adoption of LED lighting in households, with 47% relying on LEDs for indoor illumination. Moreover, the fact that LED lights constituted 65% of all lighting sales in the U.S. underscores their growing popularity. As LED technology becomes more affordable and accessible, it reduces energy consumption and contributes to cost savings, aligning with sustainability goals and shaping the future of lighting solutions.

Smart LED lighting synergy with advanced generation propels market boom, supplying energy-efficient, customizable illumination. Remote control, scheduling, and IoT integration force massive adoption in houses and corporations. The surge in demand displays a preference for smart, linked solutions. Concurrently, UV LED addresses health issues through disinfection applications, while Horticultural LEDs meet the needs of controlled agriculture, optimizing crop growth. These specialized applications, driven through LED advancements, diversify the market, emphasizing performance and flexibility. The confluence of smart0 lighting, UV LEDs, and Horticultural LEDs positions the LED lighting market at the forefront, leading the way in revolutionary and sustainable light solutions. So, the LED Lighting Market growth is expected to be valued at about US$ 128.15 Billion by 2030.

Besides, government projects greatly influence the LED lighting market, steering adoption and shaping enterprise traits. Governments globally propel the shift to power-efficient LED lights through incentives, policies, and public projects. Environmental regulations phase out traditional lights, fostering sustainability. For instance, the U.S. Environmental Protection Agency (EPA) states that LED lights dissipate 90% less energy than traditional incandescent bulbs and last up to 25 times longer. Smart city tasks combine LEDs for efficient city lights. Also, the European Commission’s SWITCH to LED campaign promotes LED lighting benefits, urging consumers and businesses to switch. This strategic push aligns with energy goals, strengthening LED’s dominance in the global lighting market, driven by energy savings, environmental advantages, and cost efficiency.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=led-lighting-market-p.php 

The luminaires segment is poised for substantial expansion, emerging as a pivotal player in the global LED lighting market.

Forecasts imply a high surge in growth, with luminaires expected to command a bigger share. This trend underscores the increasing demand for advanced lighting solutions driven by energy performance and innovative design. As the sector embraces LED technology, the luminaires segment’s ascendancy reflects a shift closer to sophisticated, eco-friendly illumination, signaling a bright future for the arena in the broader lighting solutions landscape.

Product Type – LED Lighting Market has been covered from two viewpoints.

  1. Lamps
  2. Luminaires

The indoor segment is primed to dominate the global LED lighting market, securing the highest share.

The ascendancy in the indoor segment is attributed to a surge in demand for energy-efficient and aesthetically captivating lighting fixture solutions in residential, business, and industrial areas. LED technology focuses on improving indoor environments and provides cost-efficient, long-lasting illumination, aligning with sustainability needs. As focus grows and retrofitting becomes conventional, the indoor segment is poised to preserve its market lead, reflecting the pervasive adoption of LED lighting fixtures throughout numerous indoor settings.

Application –The LED Lighting Market has been covered from two viewpoints.

  1. Indoor
  2. Outdoor

The commercial sector has clinched the largest global LED lighting market share.

Companies are adopting LED lighting for offices, retail spaces, and hospitality in pursuit of cost savings and sustainability. The technology’s performance, durability, and design versatility align with industrial establishments’ needs. Government incentives and growing recognition further propel this adoption, solidifying the economic area’s dominance. As the sector pivots closer to electricity-efficient solutions, the commercial segment continues to shine as a beacon of LED market management.

End-Users – The LED Lighting Market has been covered from four viewpoints.

  1. Commercial
  2. Residential
  3. Industrial
  4. Others

E-commerce is experiencing a surge in the LED lighting market as online platforms provide convenient access to various lighting solutions.

Consumers are attracted to the ease of surfing and comparing LED merchandise in the e-commerce medium, having access to distinct specifications, and reading critiques before buying. The virtual panorama facilitates efficient distribution channels and swift adoption of electricity-efficient lighting fixtures. The growing need for smart light alternatives accentuates this trend. E-commerce’s accessibility and variety contribute significantly to the flourishing presence of LED lighting in the international market.

Sales Channel– LED Lighting Market has been covered from three viewpoints.

  1. Retail/Warehouse
  2. E-Commerce
  3. Direct Sales by Sales Channel

India is seeing a multifaceted surge in the global market for LED lighting.

Government initiatives like UJALA, promoting LED adoption, and electricity efficiency mandates have multiplied the shift. The nation’s expanding urban panorama, business growth, and burgeoning middle class emphasize the demand for sustainable lighting solutions. A robust production surroundings ensures competitive prices. Moreover, awareness campaigns, growing environmental cognizance, and the push towards smart cities contribute to the LED market’s upswing. With a confluence of policy support, economic elements, and changing consumer alternatives, India has emerged as a pivotal player in the global LED lighting market, witnessing tremendous expansion.

Country – This report covers the 26 countries LED Lighting Market

1.    North America

1.1    United States

1.2    Canada

2.    Europe

2.1    France

2.2    Germany

2.3    Italy

2.4    Spain

2.5    United Kingdom

2.6    Belgium

2.7    Netherland

2.8    Turkey

3.    Asia Pacific

3.1    China

3.2    Japan

3.3    India

3.4    Australia

3.5    South Korea

3.6    Thailand

3.7    Malaysia

3.8    Indonesia

3.9    New Zealand

4.    Latin America

4.1    Brazil

4.2    Mexico

4.3    Argentina

5.    Middle East & Africa

5.1    Saudi Arabia

5.2    UAE

5.3    South Africa

6.    Rest of the World

Competitive Landscape

The report on the LED lighting market features a profile of several significant players, namely Acuity Brands Inc., Hubbell Inc., Daktronics Inc., LSI Industries Inc., Samsung Electronics Co. Ltd., and Koninklijke Philips N.V.

Company Insights

  • Overview
  • Recent Development and Initiatives
  • Sales Analysis

Analysis of the companies present in the LED Lighting Market.

  1. Acuity Brands Inc.
  2. Hubbell Inc.
  3. Daktronics Inc.
  4. LSI Industries Inc.
  5. Samsung Electronics Co. Ltd.
  6. Koninklijke Philips N.V.

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Lithium-ion Battery Market, Size, Share, Insights and Key Players | Forecast (2023 – 2030)

Comprehensive industry analysis and market share data in the recently released report “Lithium-ion Battery Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2028″ by Renub Research. The report also analyses competitors, geographical areas, and expansion for Lithium-ion Battery Market.

A CAGR of 16% is projected for the lithium-ion battery market between 2024 and 2028.Lithium-ion batteries, renowned for their high energy density and efficiency, play a pivotal role in powering electronic devices, electric vehicles (EVs), and renewable energy systems. Moreover, ongoing breakthroughs in lithium-ion battery tech, crucial for elevating energy density and safety, are propelling market growth and expanding applications, notably in electric vehicles, reinforcing the shift to sustainable transportation. Also, the consumer electronics sector benefits from longer-lasting and more efficient batteries, improving the performance and convenience of devices. In renewable energy storage, advanced lithium-ion batteries are integral to optimizing the utilization of renewable sources, promoting a more sustainable and resilient energy ecosystem.

Likewise, surging demand for electric vehicles (EVs) is reshaping the lithium-ion battery market panorama. As the automobile enterprise accelerates its transition to cleaner, electric-powered mobility, the demand for lithium-ion batteries, with their excessive energy density and efficiency, is skyrocketing. This surge now drives market growth and spurs advancements in battery technology. Manufacturers are scaling manufacturing to satisfy the EV demand, contributing to accelerated innovation and economies of scale, further solidifying lithium-ion batteries as the cornerstone of the swiftly increasing electric vehicle market. So, the Lithium-ion Battery Market is expected to be valued at about US$ 120.65 Billion by 2028.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=lithium-ion-battery-market-application-material-companies-p.php

Besides, incentives, subsidies, and regulatory support encourage the adoption of clean energy solutions, intensifying the demand for lithium-ion batteries. For instance, in 2023, the global lithium-ion battery market received significant boosts from government initiatives, such as the Biden administration’s $3.2 billion investment in the United States to support domestic manufacturing and China’s policies, including subsidies for battery manufacturers and tax breaks for electric vehicle buyers, fostering development and sustainability. As governments worldwide prioritize decarbonization and sustainability, the market experiences accelerated growth. These initiatives stimulate innovation and research and position lithium-ion batteries as essential components in the global transition towards a more sustainable energy landscape.

Cathodes dominate the lithium-ion battery market due to their pivotal role in enhancing performance and longevity. 

Cathodes contribute appreciably to strength density as a vital factor, determining the battery’s overall efficiency and ability. Ongoing research focuses on enhancing cathode substances, such as nickel-rich formulations, to reinforce energy storage and lifespan. Their compatibility with various applications, from consumer electronics to electric cars, solidifies cathodes as the cornerstone, commanding the most considerable market percentage in the dynamic and unexpectedly increasing lithium-ion battery market.

Components – Lithium-ion Battery Market has been covered from four viewpoints.

  1. Cathode
  2. Anode
  3. Electrolytic Solution
  4. Others

Lithium Manganese Oxide (LMO) is emerging as the fastest-growing segment in the lithium-ion battery market due to its advantageous performance and safety balance. 

Lithium Manganese Oxide (LMO) batteries offer excellent stability and thermal resistance, making them ideal for high-demand applications like power tools and medical devices. Their growing popularity stems from the need for dependable, non-flammable energy storage solutions. With advancements in LMO technology, they are poised to play a pivotal role in the future of electric mobility and grid storage, further propelling their rapid market expansion.

Product Type – Lithium-ion Battery Market has been covered from six viewpoints.

  1. Lithium Cobalt Oxide (LCO)
  2. Lithium Iron Phosphate (LFP)
  3. Lithium Manganese Oxide (LMO)
  4. Lithium Nickel Cobalt Aluminium Oxide (NCA)
  5. Lithium Titanate
  6. Lithium Nickel Manganese Cobalt

Passenger Electric Vehicles (EVs) are positioned to lead the lithium-ion battery market because of the accelerating global shift toward sustainable transportation. 

The growing popularity of Passenger Electric Vehicles (EVs) is propelled by advancements in battery technology, improving variety and performance. As governments incentivize EV adoption and automakers invest in electrification, passenger EVs are becoming more reachable and appealing, with ongoing research driving innovation. Lithium-ion batteries’ flexibility and environmental benefits are the number one preference for powering the increasing fleet of Passenger EVs worldwide.

Application – Lithium-ion Battery Market has been covered from five viewpoints.

  1. Passenger EVs
  2. Commercial EVs and Electric two/three wheelers
  3. E-buses
  4. Stationary Storage
  5. Consumer Electronics

India is poised to dominate the lithium-ion battery market. 

The dedication of India to electric-powered mobility aligns with global sustainability goals, fostering considerable investments in battery technology and manufacturing. With a large patron base and formidable government tasks, India is becoming a key player in the EV market. In a significant move, India released the National Centre for Battery Testing (NCBT) in February 2023 to ensure the quality and safety of domestically synthetic lithium-ion batteries. This cutting-edge facility gives critical testing and certification services. Simultaneously, the Indian government has solid worldwide collaborations through MOUs with international locations like Australia, the UK, and the US, in addition to with groups like Tesla and Panasonic. The drive towards energy independence and a sturdy ecosystem for battery manufacturing position India as a leader, equipped to form the lithium-ion battery market in the coming years.

Countries – Lithium-ion Battery Market has been covered from five viewpoints.

1.    North America

1.1    United States

1.2    Canada

2.    Europe

2.1    Poland

2.2    Germany

2.3    Spain

2.4    France

2.5    United Kingdom

2.6    Italy

2.7    Netherlands

2.8    Turkey

2.9    Others in Europe

3.    Asia-Pacific

3.1    China

3.2    Japan

3.3    South Korea

3.4    India

3.5    Australia

3.6    Indonesia

3.7    Thailand

3.8    Malaysia

3.9    Others in Asia-Pacific

4.    Middle East and Africa

4.1    Saudi Arabia

4.2    UAE

4.3    South Africa

4.4    Others in Middle East and Africa

5.    Latin America

5.1    Brazil

5.2    Argentina

5.3    Chile

5.4    Mexico

5.5    Others in Latin America

Competitive Landscape

The top producers of lithium-ion batteries are Exide Technologies, Johnsons Controls Inc., Samsung SDI Company Limited, BYD Company Ltd., and GS Yuasa Corporation.

Company Insights.

  • Overview
  • Recent Development and Initiatives
  • Sales Analysis

Analysis of the companies present in the Lithium-ion Battery Market.

  1. Exide Technologies
  2. Johnsons Controls Inc.
  3. Samsung SDI Company Limited
  4. BYD Company Ltd.
  5. GS Yuasa Corporation

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Narcolepsy Drugs Market, Size, Share, Growth | Forecast ( 2023-2028 ) | Renub Research

The recently released report “Narcolepsy Drugs Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2030” by Renub Research provides extensive industry analysis and market share data. The study examines the clinical Narcolepsy Drugs Market competitors, geographic regions, and growth prospects.

Narcolepsy Drugs Market is expected to grow at a compound annual growth rate (CAGR) of 8.01% between 2023 and 2030.Since narcolepsy is a chronic neurological disorder marked by immoderate daytime sleepiness, cataplexy, and disrupted nocturnal sleep, the market for narcolepsy drugs has grown and changed. Narcolepsy Network estimates the worldwide occurrence of narcolepsy at 0.05%, indicating around 1 in 2,000 humans worldwide, or about three million individuals, are affected. Due to the demanding situations in diagnosis, many cases may be neglected, suggesting the actual incidence should exceed 0.05%. This underscores the significance of heightened consciousness, increased diagnostics, and advancements in pharmaceutical solutions to deal with the potential underreporting of this neurological ailment on a broader scale.

Sodium oxybate emerges as a standout in the narcolepsy drugs market thanks to its splendid efficacy in addressing cataplexy and enhancing nocturnal sleep quality, making it a comprehensive treatment choice. The exclusive benefits associated with sodium oxybate notably contribute to its market dominance. Also, diagnostics facilities are pivotal in propelling the narcolepsy drugs market forward. They are important in ensuring accurate and well-timed diagnoses for effective remedy initiation. With advanced sleep studies and diagnostic equipment available, these centers facilitate precise condition assessments, guiding healthcare providers in tailoring drug treatment plans to meet the unique needs of individual patients. Hence, the Narcolepsy Drug Market is projected to reach US$ 5.95 Billion by 2030.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=narcolepsy-drugs-market-p.php

Moreover, the narcolepsy drugs market in Asia is experiencing significant growth due to heightened awareness and improved diagnostics. Lifestyle changes and stress contribute to rising narcolepsy rates. Collaborations between global pharmaceutical companies and local healthcare institutions foster innovation while streamlined regulatory approvals and enhanced medication accessibility drive market expansion. Asia emerges as a key region in the evolving narcolepsy drug landscape, supported by government initiatives like Japan’s Ministry of Health, Labour and Welfare fast-tracking approvals for rare disease drugs and providing subsidies for approved medications, including narcolepsy drugs.

Daytime extreme sleepiness, a hallmark of narcolepsy, fuels demand for effective medications, propelling growth in the narcolepsy drugs market.

As the daytime extreme sleepiness symptom profoundly influences patients’ daily lives, pharmaceutical improvements concentrated on its mitigation become pivotal. The market’s trajectory hinges on innovations addressing not simply typical narcolepsy management but specifically preventing daylight sleepiness. Consequently, pharmaceutical agencies investing in groundbreaking solutions for this section gain an aggressive edge, shaping the market panorama and influencing the treatment paradigm for narcolepsy patients.

Disease Types – The Narcolepsy Drugs Market has been covered from three viewpoints.

  1. Daytime Extreme Sleepiness
  2. Cataplexies
  3. Other

Sodium oxybate holds prominence in the narcolepsy drugs market due to its unique efficacy in managing cataplexy and improving nocturnal sleep quality.

As the primary aspect of Xyrem, sodium oxybate addresses more than one aspect of narcolepsy signs and symptoms, distinguishing itself as a comprehensive remedy option. The drug’s potential to enhance sleep consolidation and decrease cataplexy episodes sets it aside, making it a preferred choice for healthcare providers and patients. The wonderful advantages related to the sodium oxybate segment contribute notably to its prominence in the narcolepsy pharmaceutical panorama.

Therapeutic Type – Narcolepsy Drugs Market has been covered from five viewpoints.

  1. Central Nervous system stimulants
  2. Tricyclic Antidepressants
  3. Sodium Oxybate
  4. Selective Serotonin Reuptake inhibitors
  5. Others

Diagnostics Centers dominate the narcolepsy drugs market by securing a majority share owing to their pivotal role in accurate diagnosis.

Timely identification of narcolepsy is critical for effective treatment initiation. Diagnostics Centers, equipped with advanced sleep studies and diagnostic tools, facilitate precise condition assessment. This accuracy aids healthcare providers in tailoring drug therapies, boosting overall market demand. The pivotal role of Diagnostics Centers in ensuring proper diagnosis and subsequent treatment strategies positions them as primary contributors to the majority market share in narcolepsy drug distribution.

End-User – Narcolepsy Drugs Market has been covered from three viewpoints.

  1. Diagnostics Centers
  2. Hospitals
  3. Others

The United States spearheads the narcolepsy drugs market.

The strong healthcare infrastructure of the United States, considerable awareness campaigns, and a high incidence of narcolepsy contribute to a significant patient pool. According to the Narcolepsy Network, in 2023, the estimated incidence of narcolepsy in the United States is 2.6 individuals per 100,000 inhabitants per year, indicating the diagnosis of approximately 2.6 new cases annually for every 100,000 people. Moreover, favorable regulatory surrounding expedite drug approvals, fostering innovation. Pharmaceutical companies frequently prioritize the U.S. Market for medical trials and product launches, further propelling market leadership. The convergence of these factors establishes the United States as a pacesetter in driving improvements and dominating the narcolepsy drugs region.

Country – The Narcolepsy Drugs Market has been covered from 17 viewpoints.

  1. United States
  2. Canada
  3. Mexico
  4. Brazil
  5. United Kingdom
  6. Germany
  7. France
  8. Italy
  9. Spain
  10. Netherlands
  11. China
  12. Japan
  13. India
  14. South Korea
  15. Australia
  16. South Africa
  17. United Arab Emirates

Competitive Landscape

Among the leading players in the narcolepsy drug market are Jazz Pharmaceuticals, Ligand Pharmaceuticals, Novartis AG, Takeda Pharmaceutical, Teva Pharmaceutical, Hikma Pharmaceuticals Plc, Harmony Biosciences Holdings, and Roche Holding AG.

Company Insights

  • Overview
  • Recent Development and Initiatives
  • Sales Analysis

Analysis of the companies present in the Narcolepsy Drug Market

  1. Jazz Pharmaceuticals
  2. Ligand Pharmaceuticals
  3. Novartis AG
  4. Takeda Pharmaceutical
  5. Teva Pharmaceutical
  6. Hikma Pharmaceuticals Plc,
  7. Harmony Biosciences Holdings
  8. Roche Holding AG.

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

India Frozen Paratha Market, Size, Share, Growth | Forecast (2023-2028) | Renub Research

India Frozen Paratha Market will develop at a CAGR of 19.33 Percent from 2022–2030.  The frozen paratha Industry continues to be challenged by numerous misconceptions regarding frozen meals and the procedure in India. Initially, the Indian frozen food market was most effectively constrained to primary frozen veggies like peas and French fries. With the increasing numbers of nuclear families, the demand for frozen paratha products has been reawakened in the family.  The frozen paratha market in India is growing at a regular pace. Brands in this space have seen their products evolve from occasional party snacks to ordinary meal items that humans of every age enjoy. This growth may be attributed to the ease provided by frozen parathas, which don’t require extra preparation or culinary understanding. This method means that each family member can easily prepare a frozen meal and experience the true flavors while making the most of the high vitamin content that nicely organized frozen foods contain. Ready-to-devour (RTE) and convenience ingredients have gained increasing traction among the rising working population of India. This fashion is specifically growing amongst new-age companions, in which both individuals are busy and like short, clean, nutrient-rich meals for their circle of relatives.

Additionally, due to the evident effect of climate change, sustainable cold chain packaging is another trend that is shaping the industry. Now, industry leaders are looking to be solution-oriented in terms of packaging. Since bloodless chain storage calls for supportive packaging, groups have begun to raise consciousness about making sustainable packaging a key recognition region. The frozen paratha market nowadays features merchandise from around India, including Malabar Paratha, Lacha Paratha, Paneer Paratha, Aloo Paratha, and others. These products appeal to working professionals with advanced living requirements and rising disposable income. In reality, the fascination with contemporary food traditions is changing the eating habits and existence of young Indians, increasing the market for such brands. In a report named ” India Frozen Paratha Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2030,” issued recently by Renub Research, market share insights are incorporated along with a detailed industry analysis. The study of competitors, geographical areas, and growth for India Frozen Paratha Market is also covered in the report.

Download a free sample report to get a detailed overview of the market: https://www.renub.com/request-sample-page.php?gturl=india-frozen-paratha-market-p.php

Apart from consumer preferences and needs, market and supply chain evolution have additionally contributed to the boom of the frozen paratha industry. For instance, with rising urbanization and the growth of organized retail, modern-day grocery stores are actually equipped with cutting-edge cold chain centers. This, in turn, has caused the supply of numerous frozen paratha products on the market to increase. Further, the booming e-commerce sector has helped frozen food brands make extensive strides in terms of reach and availability. Such structures provide excessive product visibility and listing at nominal costs as compared to standard retail systems. This has created a level playing field for frozen food brands of all sizes to cater to customers and boost market penetration in this class. India Frozen Paratha Market expects to reach US$ 174.94 million by 2030, According to Renub Research.

Malabar Paratha is a prominent contender in the India frozen paratha industry.

By Туре, India Frozen Paratha market is break up into Malabar Paratha, Lacha Paratha, Paneer Paratha, Aloo Paratha and Others. Malabar Paratha, a loved gem in India’s frozen paratha industry, originates from the southern coastal location. Renowned for its layered texture and rich flavor, it stands as a staple in Indian delicacies. The frozen Malabar Paratha continues its authentic taste and comfort, catering to busy modern-day life. Whether paired with curries or enjoyed on its own, this paratha variation encapsulates lifestyle and innovation, making it a famous desire among clients looking for both convenience and a proper culinary experience.

Product Types – India Frozen Paratha Market breakup from 5 Viewpoints:

  1. Malabar Paratha
  2. Lacha Paratha
  3. Paneer Paratha
  4. Aloo Paratha
  5. Others

The Offline Channel held the biggest revenue share within the India Frozen Paratha Market.

By Distribution Channel, the Indian frozen paratha market is segmented into Offline and Online. In the Indian frozen paratha industry, offline distribution channels play a pivotal role. The Offline (departmental store) is one of the essential members of the boom of the frozen paratha market, as these shops are more convenient and possible for the customers. In addition, the availability of frozen paratha is also growing in the departmental shops. These traditional avenues encompass a huge spectrum, along with local grocery shops, supermarkets, and specialized meal markets. Given India’s diverse and geographically dispersed population, these channels facilitate direct patron access to frozen paratha, often resonating more strongly with those who decide on tactile shopping reviews. Leveraging the expansive community of offline outlets, frozen paratha producers can effectively attain various client segments, catering to varying preferences and improving marketplace penetration.

Distribution Channel – India Frozen Paratha Market breakup from 2 Viewpoints:

  1. Offline
  2. Online

North and Central India made the largest contribution to the India Frozen Paratha Market.

By Region, the Indian frozen paratha market is divided into North and Central, South, West, and East.  Due to the fact that a large part of India’s populace lives in the northern and central states, the North and Central India vicinity is expected to have the biggest sales percentage of the market. With the growing intake of frozen paratha, even the Tier-2 markets are expanding their bloodless chain infrastructure. Additional guidance and help from the government, which includes awareness packages for the coping with and usage of frozen meals, and the state governments like Gujarat, Maharashtra, Chhattisgarh, Madhya Pradesh, Haryana, and Odisha, are imparting Capex (Capital Expenditure) incentives to frozen paratha processing industries, which is also helping the increase of the India Frozen Paratha Market. The South India area is predicted to be the quickest-developing phase in the upcoming years on account of hastily growing frozen paratha varieties. The southern states like Kerala, Karnataka, and Andhra Pradesh are considered a few of the top ten important states for frozen meal intake.

The need for healthy comfort ingredients has risen in recent years as washing, peeling, and slicing time has become more confined. Because of consumer’s busy lifestyles, there’s a greater need for convenience ingredients, which circuitously favours the boom of frozen paratha merchandise. Growing urbanization, changing lifestyles, and an expanding working populace are all elements influencing the frozen paratha market’s growth. These factors might also influence the growth of the India Frozen Paratha Market in the upcoming years.

Distribution Channel – India Frozen Paratha Market breakup from 4 Viewpoints:

  1. North & Central
  2. South
  3. West
  4. East

Key Company

ID Fresh, Haldiram, Sumeru, Goeld, Aashirvad, Tasty Fresh, Buffet, Asal Foods (Milky Mist Dairy), Godrej and Wah Ustad are the market leader in India Frozen Paratha industry.  

Company has been covered from 5 Viewpoints:

  1. Overview
  2. Recent Development & Strategies
  3. Monthly all India sales (June 2022-May 2023)
  4. Major City Sales (June 2022-May 2023)
  5. Yearly Volume Analysis by Distribution Channel (June 2022-May 2023)

Company

  1. ID Fresh
  2. Haldiram
  3. Sumeru
  4. Goeld
  5. Aashirvad
  6. Tasty Fresh
  7. Buffet
  8. Asal Foods (Milky Mist Dairy)
  9. Godrej
  10. Wah Ustad

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

United States Generic Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2028

United States Generic Drug Market share is anticipated to grow at a CAGR of nearly 6.39% during 2022 and 2028. In recent years, the US generic drug market has grown extraordinarily, fundamentally transforming the pharmaceutical industry. Generic drugs have become pivotal in the US healthcare landscape, offering cost-effective alternatives to their brand-name counterparts, addressing the growing concern of rising prescription drug costs. Besides, the expiration of patents for numerous brand-name drugs has spurred the introduction of generic versions, intensifying competition, and leading to reduced prices and wider availability, ultimately propelling the remarkable growth of the United States generic drug market size.

The aging population in the United States has fuelled the demand for generic drugs as seniors frequently rely on continuous medication for chronic illnesses, underscoring the necessity for cost-effective treatment solutions. Concurrently, government initiatives such as Medicaid and Medicare actively promote generic drug use to curb healthcare costs. So, the United States Generic Drug Market is projected to be worth US$ 147.57 Billion by 2028.

The FDA’s streamlined approval process for generics has further facilitated their US generic drug market entry, making these drugs more readily available and affordable, contributing significantly to the impressive growth of the US generic drugs market size. For instance, in 2023, the FDA approved notable generic drugs in the US market, including Tiotropium Bromide Inhalation Powder (18 mcg/capsule, ANDA 211287) for treating COPD, and Safinamide Tablets (50 mg and 100 mg, ANDA 215902) for Parkinson’s disease. These approvals advance the goal of enhancing prescription drug affordability and accessibility in the US generic drug market share.

Branded generics are thriving in the United States generic drug market.

Consumers consider branded generic medications because they bring the reputation of famous pharmaceutical groups, making sure both quality and efficacy. Furthermore, branded generics provide cost savings in comparison to their brand-name counterparts, attractive to price-aware patients and healthcare providers. Regulatory companies additionally impose stringent quality standards on these products, making sure their safety and effectiveness. These factors together drive the growth of branded generics, making them a preferred choice in the US generic drug market share, offering a stability between affordability and reliability.

Request a free sample copy of the report:  https://www.renub.com/request-sample-page.php?gturl=united-states-generic-drugs-market-p.php

The demand for generic drugs to treat heart disease is growing in the US generic drug market size due to the widespread prevalence of cardiovascular conditions.

Generic heart medicinal drugs provide exceptional treatment options at appreciably lower rates as compared to brand-name counterparts, making them accessible to a larger patient population. Moreover, as patents for several branded cardiac pills have expired, generics have emerged as readily available, promoting competition, and further lowering costs. This affordability, coupled with their demonstrated efficacy, drives the growing call for widespread heart disorder medicines in the US.

Oral generics are extensively utilized and poised for growth in the United States generic drug market due to their convenience.

Patients and healthcare providers prefer oral medicines owing to ease of administration and adherence. Moreover, as several brand-name drugs go off-patent, a plethora of well-known oral options enter the market, increasing competition and lowering costs. The accessibility, affordability, and effectiveness of those oral generics make them a famous choice, contributing to their continuous growth in the United States generic drug market share.

The retail pharmacy market has been steadily growing in the US generic drug market size.

Convenience plays a vast role as patients choose accessible locations for medicinal drug purchases. Moreover, the growing wide variety of uninsured or underinsured individuals in the US has caused a greater reliance on generic drugs due to their affordability. Furthermore, retail pharmacies offer an extensive range of generic medicines, and their promotional tasks regularly emphasize cost-saving advantages, propelling the steady rise of this market section.

The adult age group has witnessed substantial growth in the United States generic drug market share.

As people age, they are much more likely to require ongoing medication for chronic health situations, making cost-effective generics an appealing option. Moreover, coverage plans and Medicare often encourage or require the usage of generic drugs to lessen healthcare costs. The older population and the superiority of chronic diseases amongst adults in addition raise the demand for generic medicinal drugs, driving their extensive growth in this demographic section of the US generic drug market.

The increase in commercial payments in the US generic drug market size is primarily driven by the cost-effectiveness of generic medications.

Many industrial insurance plans and employers encourage using generics to lessen healthcare costs for both themselves and their personnel. As a result, more individuals are choosing generic drugs over brand-name counterparts to decrease their out-of-pocket charges. This trend aligns with the broader healthcare fee containment techniques, propelling the boom of commercial payments in the US generic drug market size.

California is at the forefront of the United States generic drug market.

It boasts a robust pharmaceutical industry, with numerous companies engaged in generic drug manufacturing and distribution. The state’s large and diverse population creates a substantial demand for generic medications. Furthermore, California has a proactive regulatory environment and promotes healthcare policies that prioritize affordability, making it an ideal location for generic drug companies. These factors collectively position California as a leader in the US generic drug market share, influencing both supply and demand within the industry.

Competitive Landscape.

Abbott Laboratories Inc., Viatris, Sandoz, Dr. Reddy’s, Aurobindo Pharma, Sun Pharmaceuticals, Teva Pharmaceuticals, Lupin Pharmaceuticals Inc., and Abbott Laboratories Inc. are significant United Staes generic drug market participants.

Market Summary.

  • Type- United States Generic Drug Market share breakup by type in 2 viewpoints (Branded Generics, Unbranded Generics).
  • Therapeutic Area- The Report covers US Generic Drug Market share by therapeutic area breakup in 10 viewpoints (Heart Disease, Mental Health, Diabetes, Epilepsy, Cancers, Allergies & Asthma, Chronic Obstructive Pulmonary Disease, Alzheimer’s Disease, HIV/AIDS, Crohn’s colitis).
  • Drug delivery- United States Generic Drug Market size breakup by drug delivery in 4 viewpoints (Oral, Injectable, Dermal/Topical, Inhalers)
  • Distribution Channel- The Report covers US Generic Drug Market share by distribution channel in 4 viewpoints (Specialty Pharmacy, Retail Pharmacy, Hospital Pharmacy, Online Pharmacy).
  • Age group- United States Generic Drug Market size breakup by age group in 4 viewpoints (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (65+ years)).
  • Payment Type- The Report covers US Generic Drug Market share by payment type breakup in 4 viewpoints (Cash, Commercial, Medicare D, Medicaid).
  • States- Renub Research report on US Generic Drugs Market covers by states in 11 viewpoints (California, Texas, New York, Florida, Pennsylvania, Ohio, Illinois, North Carolina, Georgia, Michigan, Others).
  • Key Players- All the major players of United States Generic Drug Market have been covered from 4 Viewpoints (Overview, Strategy, Merger/Acquisition, and Financial Insight) Abbott Laboratories Inc., Viatris, Sandoz, Dr. Reddy’s, Aurobindo Pharma, Sun Pharmaceuticals, Teva Pharmaceuticals, Lupin Pharmaceuticals Inc., and Abbott Laboratories Inc.

Browse Related Reports: 

Alzheimer’s Drugs Market: https://www.renub.com/alzheimer-s-pipeline-drugs-review-alzheimer-s-disease-drug-market-and-forecast-global-analysis-131-p.php

Diabetes Drug Market: https://www.renub.com/diabetes-drug-market-p.php

Schizophrenia Drugs Market: https://www.renub.com/schizophrenia-drugs-market-p.php

Osteoporosis Drugs Market: https://www.renub.com/global-osteoporosis-market-patients-companies-and-forecast-483-p.php

Narcolepsy Drugs Market: https://www.renub.com/narcolepsy-drugs-market-p.php

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Single Use-Disposable Endoscopes Market, Size, Share, Growth, Key Players | Forecast (2023-2028) | Renub Research

In a recent report titled “Single Use Disposable Endoscopes Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2030,” Renub Research offered a thorough industry analysis that included market share insights. The report also includes research on rivals, market segments, and recent developments in the Single Use Disposable Endoscopes Market.

Single Use Disposable Endoscopy Market will expand at a CAGR of almost 18.04% during 2022 and 2030. In recent years, the single-use disposable endoscopes market has experienced awesome growth, remodelling the landscape of medical diagnostics and processes. These innovative devices, designed for one-time use, are gaining popularity throughout numerous medical specialties, such as gastroenterology, pulmonology, and urology. This adaptability makes them an attractive choice for healthcare providers seeking to optimize their sources and offer fantastic care across a spectrum of medical needs.

The rapid expansion of the global single-use disposable endoscopy market is primarily driven by an intensified focus on infection control and patient safety. Unlike reusable endoscopes, which may carry residual contaminants despite stringent cleaning and sterilization, disposable endoscopes eliminate the need for reprocessing, ensuring a sterile and uncontaminated instrument for each procedure. Likewise, the convenience they offer is noteworthy, as traditional endoscopes demand meticulous cleaning, maintenance, and sterilization between uses, posing logistical challenges in busy healthcare settings. In contrast, disposable endoscopes are ready for use straight out of the packaging, streamlining workflow and reducing downtime between procedures. So, Single Use Disposable Endoscopes Market will achieve a value of US$ 6.71 Billion by 2030.

Furthermore, regulatory agencies and healthcare institutions are increasingly endorsing the use of single-use disposable endoscopes to enhance patient safety. The Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) in the United States, for instance, have issued guidelines and recommendations that align with this trend, further accelerating global single use disposable endoscopy market growth.

Endoscopes hold a dominant position in the disposable endoscope market due to their versatility, and efficiency in various medical procedures.

Endoscopes provide physicians real-time visualization of internal organs, minimizing invasive surgeries. Single-use disposable endoscopes, mainly, lessen the threat of cross-contamination and infections, improving patient safety. Moreover, they dispose of the want for reprocessing and protection, streamlining healthcare workflows. These advantages make endoscopes the favoured choice in the market, using their persisted dominance as a vital clinical device for diagnostic and healing applications.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=single-use-disposable-endoscopy-market-p.php

Bronchoscopy is likely to lead the single-use disposable endoscopes market owing to its frequent use in diagnosing and treating respiratory conditions.

Single-use disposable bronchoscopes offer several benefits, which includes reducing the danger of contamination transmission and putting off the want for reprocessing. With a developing emphasis on contamination control and patient protection, healthcare providers increasingly choose these disposable devices for bronchoscopic tactics. This trend is predicted to enhance the prominence of bronchoscopy programs in the disposable endoscopes market, reflecting its essential position in respiration healthcare while aligning with infection prevention protocols.

The hospital segment is poised to maintain the largest share in the single-use disposable endoscopes market.

Hospitals conduct a wide range of procedures where contamination control and patient protection are paramount, making single-use disposable endoscopes an appealing choice. Their convenience, decreased chance of cross-infection, and removal of reprocessing fees align with medical institution protocols. Also, the sheer volume of clinical approaches performed in hospitals, which include surgical procedures and diagnostic examinations, guarantees a constant demand for these disposable devices, contributing to their dominant position in the disposable endoscope market.

The United States is expected to maintain a high share in the global single-use disposable endoscopy market.

The U.S.A has a robust healthcare infrastructure with an excessive extent of clinical processes, and a strong focus on infection control and patient protection. Regulatory groups in the US also promote the adoption of disposable endoscopes for decreasing cross-contamination risks. Moreover, ongoing technological improvements and a well-established healthcare sector contribute to the ongoing increase and dominance of United States of America in the single-use disposable endoscopes market over the forecast period.

Competitive Landscape.

Boston Scientific Corporation Inc., Hill Rom Holdings, Coloplast, Medtronic Plc, Cantel Medical Corporation, Alcon, and HCA Healthcare Inc. are a few of the sizable companies vying for market share in the global single-use disposable endoscopy market.

Market Summary.

  • Product Type – Global Single-Use Disposable Endoscopy Market by product type have been covered from 5 viewpoints (Endoscope, Visualization Systems, Endoscopic Ultrasound, Insufflator &Others)
  • Application – Single-Use Disposable Endoscope Market by application have been covered from 6 viewpoints (Bronchoscopy, GI endoscopy, ENT Endoscopy, Urologic endoscopy, Arthroscopy & Others)
  • End Use – Single-Use Disposable Endoscopy Market by end-use have been covered from 3 viewpoints (Hospital, Health Care Centre &Clinics)
  • Country – Single-Use Disposable Endoscopes Market have been covered from 23 viewpoints (United States, Canada, Germany, United Kingdom, France, Italy, Netherlands, Spain, China, South Korea, Japan, India, Indonesia, Malaysia, Argentina, Brazil, Mexico, Colombia, Saudi Arabia, South Africa, Israel, Australia & UAE).
  • Key Players- All the major players of Global Single-Use Disposable Endoscopy Market have been covered from 3 Viewpoints (Overview, Recent Development & Revenue) Boston Scientific Corporation Inc, Hill Rom Holdings, Coloplast, Medtronic Plc, Cantel Medical Corporation, Alcon & HCA Healthcare Inc.

Browse Related Report:

Medical Adhesives Market: https://www.renub.com/medical-adhesives-market-p.php

Global Insulin Pen Market: https://www.renub.com/insulin-pen-market-p.php

Transcatheter Heart Valve Replacement Market: https://www.renub.com/transcatheter-heart-valve-replacement-market-p.php

Cardiac Bio Implant Devices Market: https://www.renub.com/cardiac-bio-implant-devices-market-p.php

Radiation Dose Management Market: https://www.renub.com/radiation-dose-management-market-p.php

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Prefilled Syringes Market, Size, Share, Growth & Insights | Forecast (2023-2028) | Renub Research

Renub Research presented a report on “Prefilled Syringes Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2029,” which presents a comprehensive industry analysis that includes market share insights, competitor research, global geographic markets, and recent Prefilled Syringes Market Size expansion.

Prefilled Syringes Market Size is foreseen to experience a CAGR of 10.34% from 2022 to 2029. Generally, the need for prefilled syringes is being driven by the growing occurrence of persistent diseases and the developing need for common drug administration. Conditions like diabetes, rheumatoid arthritis, and multiple sclerosis require daily injections, making prefilled syringes a preferred choice for patients and healthcare providers. They offer accurate dosing, lessen the chance of medication errors, and enhance patient compliance, ultimately improving the management of chronic illnesses.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=prefilled-syringes-market-p.php

Moreover, the upward push in biologics and biosimilars is a key driver of global prefilled syringes market size growth. Biologic pills, which consist of monoclonal antibodies and vaccines, are increasingly more used in the treatment of various diseases, along with cancer, autoimmune issues, and infectious diseases. Prefilled syringes are well-suited for the delivery of biologics because they provide a sterile, ready-to-use solution, ensuring the integrity and efficacy of those sensitive medications. Moreover, as the development of biosimilars quickens, prefilled syringes are instrumental in offering cost-effective and accessible alternatives to expensive biologic remedies, further propelling global prefilled syringes market size growth. Thus, the Global Prefilled Syringes Market is anticipated to reach a value of $15.63 Billion by 2029.

Furthermore, the ageing population, especially in developed areas, contributes to the increase of the prefilled syringes market size. Elderly people often require regular injections for conditions like osteoporosis, anticoagulation remedy, and hormone alternative. Prefilled syringes simplify the management system for both patients and caregivers, making them a desired need in geriatric care settings. As the worldwide healthcare panorama keeps to adapt, the versatility, safety, and comfort of prefilled syringes positions them as a critical factor in the pharmaceutical and healthcare industries, propelling their outstanding growth.

The reusable prefilled syringes class is poised for the quickest increase within the global prefilled syringes market because of its environmental sustainability.

The reusable prefilled syringes offer a cost-effective and eco-friendly alternative, lowering medical waste and resource intake. Healthcare companies and patients are increasingly opting for reusable alternatives, aligning with the worldwide fashion towards greater sustainable healthcare practices. This shift towards reusable prefilled syringes reflects a developing emphasis on both monetary and environmental considerations in the healthcare industry.

The glass prefilled syringes command the highest share in the prefilled syringes market due to their considerable use in prescription drugs and biotechnology sectors.

Glass syringes are favoured for their compatibility with a wide variety of medicine, preserving drug balance and integrity. They also provide tremendous visibility, facilitating accurate dosage administration. These traits make glass prefilled syringes a top choice for pharmaceutical corporations and healthcare providers, accounting for the significant proportion in the global prefilled syringes market size.

The dominance of the single-chamber prefilled syringes design in the global prefilled syringes market is attributed to its versatility and significant applicability.

Single-chamber syringes are rather adaptable for diverse drug formulations, from vaccines to biologics and injectable medicines. They provide simplicity in layout, ease of use, and efficient drug delivery, making them the favoured alternative for pharmaceutical corporations and healthcare practitioners. This design’s capacity to cater to an extensive range of therapeutic applications has caused its majority share in the prefilled syringes market.

The diabetes section commands a giant share in the prefilled syringes market size due to the extensive prevalence of diabetes globally.

Patients with diabetes require everyday insulin injections, and prefilled syringes offer a convenient, precise, and customer-friendly technique for administering insulin doses. With the growing global diabetic populace, there may be a developing demand for these prefilled syringes, making the diabetes section a giant player within the global prefilled syringes market, driven by the need for effective and reachable insulin delivery solution.

The demand for hospital within the global prefilled syringes market is on a rise.

Hospitals are fundamental healthcare hubs in which an extensive variety of medicines and vaccines are administered each day, necessitating efficient and accurate drug delivery structures. Prefilled syringes offer comfort, decreased hazard of medicine errors, and time-saving benefits, making them an appealing choice for hospitals seeking to enhance patient care and streamline their healthcare approaches. This developing popularity of the benefits of prefilled syringes is probably to force accelerated adoption among hospital end-users in the prefilled syringes market.

Asia Pacific is anticipated to experience the fastest growth in the global prefilled syringes market.

Rising healthcare expenses, increasing access to healthcare services, and growing awareness of the benefits of prefilled syringes are propelling market growth in the area. Furthermore, a growing ageing population and the superiority of chronic sicknesses necessitate more frequent injections, boosting need. Likewise, improvements in healthcare infrastructure and a burgeoning pharmaceutical industry in countries like China and India are contributing to the quick expansion of the prefilled syringes market size in Asia Pacific.

Competitive Landscape

Abbott Laboratories, Bayer AG, Baxter International, Becton Dickinson, Catalent, Inc., Gerresheimer AG, and Medtronic Plc. are notable companies currently engaged in competition in the global prefilled syringes market.

Market Summary.

  • Type- The Report covers Prefilled Syringes Market, by type in 2 viewpoints (Disposable, and Reusable).
  • Material- By material, the Prefilled Syringes Market, breakup in 2 viewpoints (Glass, and Plastic).
  • Application- The Report covers Prefilled Syringes Market, by application in 5 viewpoints (Diabetes, Rheumatoid Artheitis, Anaphylaxis, Antithrombotic/Thrombolytic Therapy, Others).
  • Design- – By design, the Prefilled Syringes Market, breakup in 3 viewpoints (Single-chamber, Dual-Chamber, and Customized).
  • Distribution Channel- Renub Research report covers by distribution channel in 4 viewpoints (Hospital, Blood Collection Centers, Diabetic Care Centers, and Others).
  • Region- The Prefilled Syringes Market by region breakup in 5 viewpoints (North America, Europe, Asia-Pacific, Latin America, and Middle-East).
  • Key Players- All the major players have been covered from 3 Viewpoints (Overview, Recent Developments, and Revenue) Abbott Laboratories, Bayer AG, Baxter International, Becton Dickinson, Catalent, Inc., Gerresheimer AG, and Medtronic Plc.

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

India snacks market is set to hit US$ 23.69 Billion by 2028, Size, Share, Outlook | Renub Research

Renub Research has recently published a report named “India Snacks Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis” providing a detailed industry analysis that consists of market share insights. Furthermore, the report studies competitors and regions and the recent India Snacks Market growth. India snacks market projects a CAGR of 12% during 2023-2028.The snacks industry in India is a thriving and dynamic sector that caters to the diverse and evolving snacking preferences of the country’s population.

With a rich culinary heritage and a growing consumer base, the Indian snacks industry has witnessed remarkable growth in recent years. India’s snacks industry is characterized by a wide variety of traditional and innovative snack options that cater to different taste preferences and regional preferences. From savory snacks like namkeens, bhujia, and samosas to sweet delicacies like jalebis and ladoos, the Indian snacks market offers a vast array of choices to consumers. India snacks market is set to hit US$ 23.69 Billion by 2028, fuelled by changing lifestyles, rising income, urbanization, evolving snacking habits, innovation, organized retail, and effective marketing strategies. India snacks market is set to hit US$ 23.69 Billion by 2028, fuelled by changing lifestyles, rising income, urbanization, evolving snacking habits, innovation, organized retail, and effective marketing strategies.

One of the key factors driving the growth of the healthy snacks market size in India is the changing lifestyle patterns of consumers. With hectic schedules and increasing urbanization, there is a rising demand for convenient, on-the-go snacking options. This has led to the emergence of packaged snacks, such as potato chips, extruded snacks, and ready-to-eat namkeens, which offer convenience, portability, and longer shelf life. Furthermore, the increasing influence of western culture and exposure to global cuisines has contributed to the diversification of theIndian snacks market size. Consumers are now embracing international snacks like nachos, popcorn, and tortilla chips alongside traditional Indian snacks.

Request a free sample copy of the report:  https://www.renub.com/request-sample-page.php?gturl=india-snacks-market-forecast-organized-unorganized-companies-consumer-survey-p.php

The snack food market in India has also witnessed significant innovation in terms of flavors, ingredients, and packaging. Companies are constantly introducing new and unique flavors to cater to the evolving taste preferences of consumers. Moreover, healthier snacking options, such as baked snacks, multigrain snacks, and organic snacks, are gaining popularity as consumers become more health-conscious. As the Indian population continues to grow, and consumer spending power increases, the snacks market share in India is expected to witness further growth and innovation. The industry’s ability to adapt to changing consumer preferences, introduce healthier alternatives, and explore new flavors and packaging formats will be key in sustaining its upward trajectory.

Dominance of the unorganized sector in the India snacks market

The unorganized sector holds a dominant position in the India snacks market due to various factors. This sector offers a diverse range of traditional snacks that are often homemade, providing a unique and authentic flavor experience. These snacks are usually more affordable compared to branded alternatives, making them accessible to a wider consumer base. The unorganized sector also benefits from its flexibility in adapting to local tastes and preferences, allowing for constant innovation and customization. With its rich cultural heritage and widespread presence, the unorganized sector continues to play a significant role in shaping the Indian snacks market.

Sector – The India Snacks Market breakup from two viewpoints

1.    Organized Snacks

2.    Un-Organized Snacks

Popularity of ethnic namkeen continues to rise, propelling the growth and diversification of the India snacks market.

The snacks market in Indian has witnessed significant growth due to the increasing demand for regional flavors and the preservation of culinary heritage. Consumers are actively seeking out ethnic namkeen snacks that showcase the authentic tastes and traditions of different regions across India. The unique blend of spices, ingredients, and cooking techniques used in these snacks creates a nostalgic and flavorful experience for consumers. This trend has prompted manufacturers to develop a wide variety of ethnic namkeen options, catering to the diverse taste preferences of consumers and contributing to the overall growth of the Indian snacks market.

Type – The India Snacks Market breakup from three Viewpoints

1.    Ethnic Namkeen & Snacks

2.    Ethnic Bhujia

3.    Western Snacks

Western region of India is poised to make a substantial impact on the snacks market in the country.

With its rich culinary traditions and diverse flavors, this region offers a wide range of snacks that cater to the evolving taste preferences of consumers. From popular street food delicacies like vadapav and bhelpuri to regional specialties like Gujarati snacks and Maharashtrian snacks, the western India region brings a unique and vibrant culinary heritage to the snacks market. As consumers increasingly explore new flavors and seek out authentic regional experiences, the snacks market in India can expect significant growth and innovation driven by the offerings from the western region.

Region – The India Snacks Market breakup from four viewpoints

1.    North India

2.    West India

3.    East India

4.    South India

Competitive Landscape

The Indian snacks market is characterized by the presence of prominent players such as Prataap Snacks, Nestle, DFM Foods Ltd, PepsiCo, ITC Limited, Britannia, and Agro Tech Foods Ltd. These companies play a crucial role in shaping the industry through their extensive product portfolios, strong distribution networks, and innovative marketing strategies.

All companies in this report have been covered with three viewpoints:

•    Overview

•    Strategy

•    Sales

Company Analysis:

1.    Prataap Snacks Ltd

2.    Nestle

3.    DFM Food Ltd

4.    PepsiCo India

5.    ITC Limited

6.    Britannia Industries

7.    Agro Tech Food Ltd

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Germany Diabetes Market Exceeds US$ 21.50 Billion in 2022: Insights from Renub Research

Renub Research has recently published a report titled “Germany Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis” providing a comprehensive analysis of the industry that includes market share insights. In addition, the report comprises competitor and regional research and contemporary extension in the Germany Diabetes Market. Germany Diabetes Market was more than US$ 21.50 Billion in 2022.Germany diabetes industry is a dynamic and rapidly growing sector at the forefront of diabetes care and research.

With a high prevalence of diabetes in the country, estimated at over 7 million individuals, the industry is focused on providing innovative solutions for diabetes management, treatment, and prevention. Innovation plays a vital role in the German diabetes industry, with a focus on developing cutting-edge medications, insulin delivery systems, glucose monitoring devices, and digital health solutions. The integration of technology, such as wearable devices, smartphone applications, and telemedicine, has revolutionized diabetes management and improved patient outcomes. Germany Diabetes Market is projected to achieve by 2028, Attributed to the development, and patient-centric approaches helps drive advancements in diabetes treatment, monitoring.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=germany-diabetes-market-p.php

Germany boasts a robust healthcare system, advanced medical infrastructure, and a strong emphasis on research and development. The industry encompasses various stakeholders, including pharmaceutical companies, medical device manufacturers, healthcare providers, research institutions, and patient advocacy groups. Germany collaborative approach between academia, industry, and healthcare providers fosters advancements in diabetes research, clinical trials, and treatment protocols. The country’s commitment to continuous education, patient empowerment, and preventive measures further strengthens the diabetes industry’s growth and contributes to better diabetes care nationwide.

Increasing prevalence of Type-2 diabetes can be attributed to the adoption of unhealthy lifestyles

The rise in Type-2 diabetes prevalence can be directly linked to the adoption of unhealthy lifestyles. Factors such as sedentary behavior, poor dietary choices, excessive sugar consumption, and a lack of physical activity contribute to the development of this chronic condition. Unhealthy lifestyle habits, including smoking, excessive alcohol consumption, and inadequate sleep patterns, further exacerbate the risk of Type-2 diabetes. These lifestyle choices have become more prevalent in modern society, leading to an alarming increase in the number of individuals affected by Type-2 diabetes. Addressing and promoting healthier lifestyle habits, including regular exercise, a balanced diet, and stress management, are crucial in curbing the growing burden of Type-2 diabetes and improving overall health outcomes.

Growing number of diabetic patients in Germany will result in an increased demand for Insulin pens

As the diabetic population continues to grow in Germany, there is a corresponding surge in the demand for Insulin pens. These compact and convenient devices have become increasingly popular among individuals with diabetes due to their ease of use, portability, and precise dosage delivery. Insulin pens offer a discreet and user-friendly alternative to traditional syringes, providing diabetic patients with greater convenience and flexibility in managing their insulin therapy. With the rising prevalence of diabetes in Germany, the demand for Insulin pens is expected to rise steadily, driving advancements in pen technologies and encouraging pharmaceutical companies to expand their production and distribution to meet the growing needs of diabetic individuals in the country.

Germany diabetes industry is witnessing significant support and encouragement through government initiatives

Government initiatives in Germany are providing substantial support and encouragement to the diabetes industry. Recognizing the growing burden of diabetes, the government has implemented various programs to address prevention, education, and treatment of the disease. These initiatives focus on raising awareness, promoting healthy lifestyles, and improving access to diabetes management resources. The government also invests in research and development, fostering innovation in diabetes care and treatment. Through collaborations with healthcare professionals, industry stakeholders, and patient advocacy groups, these government initiatives aim to enhance diabetes prevention and management strategies, ultimately improving the quality of life for individuals living with diabetes in Germany.

Competitive landscape:

Germany’s diabetes industry comprises several prominent companies, including B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nordisk, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Corp, Dexcom, Inc, Roche Diagnostics, and Tandem Diabetes Care. These companies play a crucial role in advancing diabetes care and management through their innovative products and solutions. From insulin delivery systems to glucose monitoring devices, diagnostic tools, and digital health technologies, these companies contribute to improving the lives of individuals living with diabetes in Germany.

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Europe Ultrasound Device Market Surges Towards US$ 3,085 Million by 2028: Emerging Trends and Opportunities | Renub Research

Renub Research has recently released a report titled “Europe Ultrasound Device Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis” providing a detailed industry analysis that includes market share insights. The report also includes competitor and regional research and contemporary advancements in the Europe Ultrasound Device Market. Europe Ultrasound Device Market was US$ 2,293 Million by 2022. The Europe ultrasound device market is experiencing significant growth, driven by advancements in technology, increasing prevalence of chronic diseases, rising geriatric population, and the expanding applications of ultrasound in various medical fields.

Europe has a rapidly aging population, leading to a higher demand for healthcare services and diagnostic procedures. Ultrasound devices are extensively used in obstetrics and gynecology for prenatal screenings and monitoring fetal development. Additionally, the elderly population often requires ultrasound examinations for various health issues, including cardiac evaluations, liver and kidney assessments, and musculoskeletal evaluations. The growing geriatric population in Europe is, therefore, a significant driver for the ultrasound device market. The Europe ultrasound device market is witnessing rapid technological advancements, leading to the development of more advanced and sophisticated ultrasound devices. These innovations include the integration of artificial intelligence (AI), 3D and 4D imaging capabilities, portable and handheld devices, and improved image resolution and clarity. Europe Ultrasound Device Market is expected to reach US$ 3,085 Million by 2028, Driven by Technological Advancements, Rising Demand for Point-of-Care Ultrasound and Increasing Applications in Various Medical Specialties

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=europe-ultrasound-devices-market-p.php

The prevalence of chronic diseases such as cardiovascular disorders, cancer, and musculoskeletal conditions is on the rise in Europe. Ultrasound devices play a crucial role in the diagnosis, monitoring, and treatment of these diseases. With its non-invasive nature, real-time imaging, and cost-effectiveness, ultrasound has become an essential tool for healthcare professionals in managing chronic conditions, contributing to the growth of the market. Ultrasound devices have expanded their applications beyond traditional imaging. They are now being used in interventional procedures, guidance for biopsies, monitoring of chronic diseases, and therapeutic treatments such as focused ultrasound for tumor ablation. The versatility and non-invasive nature of ultrasound make it an attractive option for various medical specialties, driving the demand for ultrasound devices in Europe.

Portable ultrasound segment is poised to dominate the ultrasound market in Europe during the forecast period

The portable ultrasound segment is projected to hold a dominant position in the ultrasound market in Europe during the forecast period. This growth can be attributed to several factors. Portable ultrasound devices offer greater convenience, flexibility, and mobility compared to traditional bulky machines, making them ideal for point-of-care settings, emergency situations, and remote healthcare environments. Additionally, technological advancements have enhanced the performance and image quality of portable ultrasound devices, enabling accurate diagnoses and improving patient care. The increasing demand for portable ultrasound devices in Europe underscores the growing trend towards portable and handheld medical devices that provide efficient and accessible diagnostic solutions.

Type – Europe Ultrasound Device Market has been covered from 2 viewpoints

1.    Stationery Ultrasound

2.    Portable Ultrasound

Ultrasound market in Europe is anticipated to witness growth in the general imaging segment, driven by the growing demand for medical imaging services

The general imaging segment in the ultrasound market is anticipated to witness substantial growth in Europe, driven by the growing demand for medical imaging services. As healthcare systems across Europe aim to enhance diagnostic capabilities and improve patient outcomes, there is an increasing reliance on ultrasound for general imaging purposes. Ultrasound offers non-invasive, cost-effective, and real-time imaging, making it a valuable tool for a wide range of applications, including abdominal imaging, obstetrics and gynecology, musculoskeletal imaging, and more. The expanding need for accurate and efficient diagnostic solutions is propelling the growth of the general imaging segment in the ultrasound market throughout Europe.

Application – Europe Ultrasound Device Market has been covered from 4 viewpoints

1.    General Imaging

2.    Cardiology

3.    Obstetrics/Gynecology

4.    Others

Demand for 2D ultrasound technology is anticipated to continue its strong presence in Europe due to its reliability and effectiveness across various medical specialties.

The demand for 2D ultrasound is set to persist in Europe, driven by its reliability and effectiveness as a versatile imaging technology employed across various medical specialties. 2D ultrasound provides valuable real-time images that aid in diagnostic evaluations, guiding procedures, and monitoring patient conditions. Its ability to visualize anatomical structures, assess organ function, and detect abnormalities has solidified its position as a fundamental imaging modality. With its non-invasive nature and cost-effectiveness, 2D ultrasound continues to be a preferred choice in Europe, ensuring its enduring significance in the medical field and meeting the ongoing demand for accurate and comprehensive imaging solutions.

Technology – Europe Ultrasound Device Market has been covered from 5 viewpoints

1.    2D Ultrasound

2.    3D & 4D Ultrasound

3.    Dopler Ultrasound

4.    High-intensity focused ultrasound (HIFU)

5.    ESWL

United Kingdom stands as the largest and most influential market for ultrasound technology in Europe.

The United Kingdom stands as the largest and most influential market for ultrasound technology in Europe. The UK boasts a well-developed healthcare system, advanced medical infrastructure, and a strong emphasis on technological innovation. The demand for ultrasound technology is driven by a combination of factors, including a high volume of medical imaging procedures, a focus on patient-centric care, and a growing aging population. The presence of leading ultrasound device manufacturers and research institutions further bolsters the UK’s influence in shaping the advancements and adoption of ultrasound technology throughout Europe.

Country – Europe Ultrasound Device Market has been covered from 7 viewpoints

1.    Germany

2.    France

3.    United Kingdom

4.    Italy

5.    Spain

6.    Poland

7.    Rest of Europe

Hospitals continue to hold a dominant position in the Europe ultrasound market

Hospitals continue to hold the dominant position in the ultrasound market across Europe. This is due to several factors that contribute to their prominence. Hospitals serve as major healthcare centers, offering a wide range of medical services and specialties. They require advanced imaging technologies like ultrasound for accurate diagnoses, monitoring patient conditions, and guiding medical interventions. Moreover, hospitals generally have a larger patient volume, leading to a higher demand for ultrasound services. The significant infrastructure and resources available in hospitals enable them to invest in state-of-the-art ultrasound equipment, making them the primary drivers of growth and adoption in the Europe ultrasound market.

End User – Europe Ultrasound Device Market has been covered from 3 viewpoints

1.    Hospital

2.    Diagnostic Center

3.    Others

Key Company

Key players in the Europe ultrasound market include Siemens AG, a renowned provider of cutting-edge ultrasound systems, Hologic, Inc. known for its expertise in women’s health imaging, Canon Medical Systems Corporation, recognized for its comprehensive ultrasound solutions, Koninklijke Philips NV, a leader in healthcare technology, and Samsung Electronics Co. Ltd., which offers innovative ultrasound products.

Key Players

1.    Hologic, Inc.

2.    Samsung Electronics Co.Ltd

3.    Canon Medical Systems Corporation

4.    Siemens AG

5.    koninklijkephilipsnv

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com